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SUMMARY 
Recently, we have characterized a membrane-bound (mb) component of  brain 
protein carboxylmethyltransferase II (PCMT) which effectively carboxylmethylates 
endogenous mb methyl-accepting proteins (MAPs). (Neurochem.  Int . ,  10 (1987) 
155). We have also shown that exposing mb-MAPs to mild alkali leads to a marked 
increase in their recognition by PCMT.  Since one of  the likely consequences of  the 
alkaline treatment appears to be the deamidation of  selected protein-bound 
asparagines or aspartates, followed by the formation, in their place, of  D-or L- 
isoaspartates, it is reasonable to assume that mb-MAPs constitute unique targets for 
the mb-PCMT because they contain such unnatural aspartate residues. Testing the 
relevance of  this notion to the aging of  cerebral mb-MAPs we focus in this report on 
age-related changes involving mb-MAPs. When two-or six-times washed (in 50 mM 
NaPO 4 buffer,  pH 6.5) 17 500 g, 30-min membranes or Percoll-gradient purified 
synaptic membranes were prepared from young (3--4 months) and old (11--12 
months) rat brains and were incubated with 20 /~M [all]methyl S-adenosyl-L- 
methionine at pH 6.0, mb-MAP carboxyl[3H]methylation was significantly more 
intense in the old than in the young membranes, no additional increase being noted 
at 28--35 months. Mb-MAP carboxylmethylation increases were confirmed over a 
wide range of  membrane protein concentrations and incubation times and are taken 
to reflect age-related modifications of  the primary structure of  susceptible mb- 
MAPs. To investigate these, we incubated young and old membranes, as well as 
their Lubrol-Px(1%) extracts (30 min, 0°C), with 0.05 M NH4OH for 90 min at 
37 °C, a treatment which left PCMT activity largely unaffected. Our findings reveal 
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that the effect of the NH4OH treatment on the generation of carboxylmethylatable 
sites was markedly smaller in "o ld"  than in "young" proteins, suggesting that 
"new" carboxylmethylatable sites are generated in susceptible mb-MAPs in situ, by 
a process accompanying, or otherwise marking, the natural aging of neural 
membrane proteins. 
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INTRODUCTION 
Although the process of cellular aging is admittedly highly complex, [1] evidence 
is accumulating to suggest that it has a molecular basis and, hence, that it may be 
profitably studied through investigations of the aging of intracellular proteins. 
Several types of modification may be incurred by proteins residing in aging cellular 
systems [2,3] and part of the relevant research has recently been summarized [4--6]. 
One type of an enzyme-catalyzed age-related protein modification is its 
carboxylmethylation. The cognate enzyme, protein carboxylmethyltransferase II 
(EC. 2.1.1.24) (PCMT) [7,8], appears to recognize only those proteins in which, via 
biological mechanisms still incompletely understood [9,10], selected L-aspartate 
residues have been replaced by D-aspartate [11] and/or L- or D-isoaspartate [12-- 
15]. Although several reports associating the presence of protein-bound D-aspartate 
with aging have appeared, [16--19] there is no unambiguous evidence for the 
presence of unnatural isoaspartates in proteins of either young or aged cells. 
Recently we have characterized in some detail a membrane-bound (mb) 
component of brain PCMT [20,21] which effectively carboxylmethylates mb 
methyl-accepting proteins (MAPs). We have also shown that exposing mb-MAPs or 
their Lubrol-P x extracts to mild alkali leads to a marked increase in their recognition 
by PCMT [22]. Since, in vitro, one of the likely consequences of the mild alkaline 
treatment appears to be the deamidation of selected protein-bound asparagines [23], 
and/or aspartates [24], followed by the formation, in their place, of unnatural 
isoaspartate(s) [25,26], it is reasonable to assume that mb-MAPs constitute unique 
targets for the mb-PCMT, because they contain unnatural aspartate residues. In the 
present report, we test the relevance of this notion to the aging of cerebral mb-MAPs 
and find that, in the rat, their treatment with mild alkali results in the generation of 
significantly fewer protein-bound sites susceptible to carboxylmethylation by the 
mb-PCMT in middle age and very old brains, than in young brains. Based on this 
and other findings, also part of this report, we propose that, as selectively vulnerable 
asparagine and/or aspartate residues of specific brain mb proteins progressively 
convert to unnatural aspartate forms in situ, the resulting increase in their 
carboxylmethylatability in vitro may represent a useful marker with which to trace 
the time course of their aging. 
163 
MATERIALS AND METHODS 
S-adenosyl-L-methionine (di-p-toluenesulfonate salt) was a gift from Dr. G. 
Stramentinoli, BioResearch, Liscate, Italy. Crystalline ovalbumin, bovine serum 
albumin, Lubrol-P x, Coomassie Blue and Percoll were from Sigma. The MW 
standards for electrophoresis were from Pharmacia. Acrylamide and N,-N'-bis- 
methylene acrylamide were from Serva. En3-Hance was from New England Nuclear. 
[3H]methyl S-adenosyl-L-methionine (1 mCi/ml) with a nominal specific 
radioactivity of 10--15 Ci/mmol was from ICN. All other reagents were of the best 
analytical grade available. 
Animals 
Rats were Sprague--Dawley, Charles River males purchased from the local 
vendor (Portage, Michigan). They were 2--4 (young), 11-- 12 (middle age) and 28-- 
35 (very old) months old. 
Preparation o f fractions 
Rat cerebra were homogenized in about 10 vols. of ice-cold 50 mM NaPO 4 buffer 
(pH 6.5) and the homogenate centrifuged at 17 500 g for 30 min. The large pellet was 
re-homogenized mechanically (8--10 up-and-down strokes) using a Teflon-tipped 
pestle rotating in a glass homogenizing tube at approximately 1200 rev./min. Pellet 
No. 2 was obtained by centrifuging as above. This pellet, one washed six times, or a 
pellet consisting of highly purified synaptic membranes (see below) were the source 
of the mb-PCMT-MAP system used throughout the study. Synaptosomes were 
prepared according to Nagy and Delgado-Escueta [27]. The collected gradient bands 
(10070--16070 Percoll interface) from several tubes were sedimented at 105 000 g for 
45 min and the pellet containing the synaptosomes was resuspended by manual 
homogenization in 3 ml of 50 mM NaPO 4 buffer (pH 6.5) for 30 min at 0°C. 
Synaptic membranes were collected by centrifugation at 105 000 g for 20 min. They 
were washed once, before resuspension and aliquoting into 1-ml portions followed 
by freezing or immediate use. 
Analytical 
Protein was determined according to Peterson [28], with crystalline bovine serum 
albumin as standard. 
Acidic slab gel electrophoresis 
The procedure described by Aswad and Deight [29] was used. A vertical slab gel 
system (SE-400, Hoefer Scientific), powered by 180 V for 3.5 h at room temperature 
provided the desired separations. After electrophoresis, portions of the slabs 
containing the radioactive proteins were treated with En3Hance according to the 
vendor's instructions and were immediately dried in a slab gel drier (Pharmacia, 
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GSD-4) at 32v, 1 amp for 2.5 h before being placed in contact with XAR-5 X-ray 
film for exposure at -70°C.  The non-radioactive proteins, run in parallel lanes, 
were stained with 0.25°7o (w/v) Coomassie Blue for 30 min and were then destained 
in 7°7o (v/v) acetic acid. 
The assay o f  PCMT activity 
(a) Acting on endogenous rob-MAPs. The procedure of Diliberto and Axelrod 
[30] was used. Each tube (255 tal) contained 5--10/acuries of [3H]methyl SAM and 
the following, at the final concentration: phosphate-citrate buffer (pH 6.0), 50 raM; 
SAM, 20 ~M; EDTA, 0.4 raM; dithiothreitol, 1.2 mM and tissue, up to 200/A [22]. 
Unless otherwise stated, the incubation was for 30 min at 37oc. 
Carboxylmethylation was arrested by the addition of 1 ml of 20°7o (w/v) TCA 
followed by 1 mg of BSA as carrier. After 15 min on ice, the tubes were centrifuged 
at 3400 rev./min for 15 min. The pellets were suspended in 0.5 ml of 0.125 M 
"borax" (Na2B407-10 H20 ) (pH 10.7), and were incubated for 5 rain at 37°C. After 
the addition of 1.2 ml of a 3:2 (v/v) mixture of toluene: isoamyl alcohol, the tubes 
were thoroughly vortexed and centrifuged at 4000 rev./min for 5 min. Two 0.5-ml 
aliquots of the upper phase, containing the released [3H]CH3OH were placed into 2 
scintillation vials for determination of the total and the carboxyl-[3H]methyl 
radioactivity. 
(b) Acting on ovalbumin. The above assay was carried out in the presence of 
100/ag of ovalbumin. 
(c) mb-PCMT activity. PCMT activity is expressed as pmol of [3H]methyl 
transferred from [3H]methyl SAM to the endogenous mb-MAPs or, when ovalbumin 
was present, to the sum of the mb-endogenous MAPs + ovalbumin. PCMT specific 
activity (spec. act.) is defined as activity/mg of protein. 
(c) The mild alkaline treatment. Six-times washed membrane pellets were 
resuspended in 50 mM NaPO 4 buffer (pH 6.5), containing the mb-PCMT-MAP 
system [22] and were then treated with 0.05 M NH4OH (see below) or, first, with 1070 
Lubrol-P x at 0°C for 30 min. In the latter case, following centrifugation at 17 500 g 
for 30 min, the resulting supernatant (SL) and pellet (PL)' (resuspended in 50 mM 
NaPO 4 buffer (pH 6.5)), were incubated in the presence of 0.05 M NH4OH for 90 min 
at 37oc, alongside controls containing no ammonia. The pH of all of the samples 
was re-adjusted to 6.5 with 1 M acetic acid (requiring 35--45 and 3--4 tal for the 
alkali-exposed and the control samples, respectively) and the amount of NH4OH- 
generated mb-MAPs was then determined in the standard assay. Separate 
experiments established that the above NH4OH treatment caused no loss of PCMT 
activity, thus obviating the necessity to use the purified cytosolic PCMT for the 
quantitation of the NH4OH-generated mb-MAPs. 
RESULTS 
Initially, the time course (10--120 min) of carboxyl-[3H]methylation of mb- 
MAPs by the mb-PCMT was compared in six-times washed membranes of young 
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and very old brains. The results (data not shown) of these experiments clearly 
demonstrated higher levels of carboxylmethylation in the very old animals' brains. 
Thus, after 60 and 120 min of incubation, respectively, we consistently found 10-- 
15 and 20--25 pmol of [3H]methyl transferred to mb-MAPs in the very old, v s .  6--7 
and 9--12 pmol in the young brains. Interestingly, however, a similar comparison of 
the mb-PCMT-MAP system (15--180 min of incubation) between synaptic 
membranes [27] of young and middle age brains revealed no significant differences 
in carbo×ylmethylation, whether this was tested in fresh or once liquid nitrogen 
frozen-thawed membrane preparations (O.Z. Sellinger and S. Fielek, unpublished 
observations). 
The significantly higher levels of protein carboxylmethylation in the six-times 
washed membranes of the very old brains are further illustrated in Fig. 1. 
[SAM]-dependent differences in carboxyl-[3H]methylation between mb-MAPs of 
young and very old six-times washed membranes are illustrated in Fig. 2. Since more 
[3H]methyl appeared to be transferred to mb-MAPs in the older membranes, a 
higher apparent Vax value for SAM obtained; however, given our inability to date to 















- r  
/ 
50 1()0 150 2()0 250 
Protein (ug)  
3oo 
Fig. 1. The effect of membrane protein concentration on the carboxyl-pH]-methylation of brain MAPs. 
Six-times washed membranes were prepared (see Methods) from brains of a young (65 days) and an old 
(341 days) rat. Suspensions containing the amounts of protein indicated were incubated for 60 min in the 
standard assay (see Methods). The values on the ordinate refer to the number of pmol transferred from 
[3H]SAM to acceptor proteins during the incubation. In three consecutive experiments the difference 
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Fig. 2. The effect of varying the concentration of SAM on the carboxylmethylation of rat brain mb- 
MAPs. The graphs shown are a composite of three separate experiments at each age, in each of which the 
effect of at least five different concentrations of SAM was compared in the presence of 456/ag of young 
(65 days) and 467/~g of old (341 days) membrane protein. Incubations were for 30 min in the standard 
assay (see Methods). 
being carboxylmethylated i.e. of the mbMAPs, we refrain from expressing the 
relevant V x values for [SAM] numerically. 
A comparison of the PCMT activity in two- v s .  six-times washed membranes of 
young, middle age and very old rat brains is presented in Table I. Although the 
specific activity of the endogenous mb-[3H]MAPs (experiment 1) diminished at all 
ages as the concentration of protein in the incubates increased, its absolute value was 
significantly higher at 11--12 than at 2--4 months at each concentration of protein 
tested. Conversely, there was little additional change in the specific activity of the 
mb-[3H]MAPs between 1 lw12 and 28--35 months of age. Further evidence for the 
middle age onset of the increase in mb-MAP carboxyl-[3H]methylation is provided 
by the marked increase (78%) of the specific activity of mb-[3H]MAPs at 11--12 
months relative to that noted at 2--4 months (experiment 2), with no further 
increase at 28--35 months. The findings of experiments 3 and 4 (Table I) also reveal 
the specific activity of the mb-[aH]MAPs to be clearly higher at 28--35 months than 
at 2--4 months, both before (experiment 3) and after solubilization (experiment 4) 
of the relevant MAPs. When assayed in the presence of ovalbumin (Table 1), BSA or 
calmodulin (data not shown), levels of mb-PCMT activity showed no consistent age- 
related fluctuations. 



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































0.05 M NH4OH for 90 min at 37°C was tested next. Table II shows that (a) mb- 
[3H]MAPs were generated in the unfractionated membranes and in the Lubrol- 
Px-derived subfractions, S L and PL; (b) a greater number of MAPs appeared after the 
NH4OH treatment in the young than in the very old brains and, consequently, (c) 
there was a significant reduction in the magnitude of the NH4OH effect in the very 
old, relative to the young brains. The uniformly negative AtNH,OH. ago values shown in 
the last column of Table II are a quantitative expression of these findings. Figure 3 
illustrates the young vs. old banding pattern of the proteins in the six-times washed 
membranes and in the synaptic membranes after Coomassie staining and following 
60-min incubation with [3H]SAM. The fluorograms reveal fewer than a dozen mb- 
[3H]MAPs. Yet, while relative to its young counterpart, the fluorogram of the six- 
times washed old mb proteins shows higher intensities of labelling in the regions of 
the slowest and fastest migrating species, the synaptic fluorograms fail to reveal 
discernible differences in labelling intensity between any of the young and old mb- 
[3H]MAPs. 
DISCUSSION 
The present findings document an increase in the carboxylmethylation of methyl- 
accepting proteins contained in thoroughly washed membranes prepared from rat 
brain at 11--12 months of age, relative to its levels determined at a single earlier (2-- 
4 months) and a single later (28--35 months) point in life. The observed increase in 
the intensity of this carboxylmethylation appears to be due, in large measure, 
although not exclusively, (see Table I, + ovalbumin) to an increased availability of 
methylatable sites in the relevant mb-MAPs (Fig. I), rather than in improvements of 
the ability of the mb-PCMT to recognize preexisting mb-MAPs. We cannot rule out, 
however, that both components of this newly characterized [22] mb-PCMT-mb- 
MAP system of brain undergo modifications in membrane structuration and/or in 
chemistry simultaneously, given our inability to date to cleanly dissociate mb-PCMT 
from its mb-MAP substrates. At present, it would appear that synaptic mb-MAPs 
are not involved. 
As recently noted by Man et  al. [19], structural changes in selected proteins of the 
human brain, such as the racemization of some of their L-aspartate residues to the 
unnatural D-form, appears to be on ongoing process, with no chronologically 
precise time-frame; indeed, protein-bound D-aspartate could be detected in the 
human brain at 10 days post-natally and was noted to peak in or close to midlife (40 
--49 years of age). Our present findings appear to be consistent with this notion, i.e. 
that, in rat brain as well, highest intensities of mb-protein carhoxylmethylation, 
presumed to occur exclusively on unnatural aspartate residues of selected proteins, 
are reached between 1/3 and 1/2 of this (laboratory-reared) rodent's life span. 
The results of preliminary HPLC analyses [31] of the acid hydrolysed mb- 
proteins contained in six-times washed membranes of both young (2m4 months) and 
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middle-age (11--12 months) rat brains are in further agreement with such 
possibilities, as they confirm the natural presence of D-aspartate in both sets of 
samples (O.Z. Sellinger and C.M. Kramer, unpublished observations). 
A chronological relationship between increased protein carboxylmethylation and 
aging has been demonstrated for proteins of the human erythrocyte [5,11,16--18]. 
Most recently, a detailed study has revealed that intrinsic proteins of the erythrocyte 
membrane, but not the erythrocyte cytosolic proteins, undergo a most intensive 
racemization of L- to D-aspartate and, also, that they accumulate other amino acid 
residues which form D-aspartate upon acid hydrolysis [16]. The latter have been 
presumed to include D-asparagine and D-isoaspartate. It is also well established, on 
the other hand, that L-isoaspartate residues, shown to be effective substrates for 
PCMT [13--15,24,25] when present in synthetic peptides [24] or when generated in 
vitro [32], may form from protein-bound L-aspartate or L-asparagine residues [33], 
via a chemical sequence, the natural occurrence of which would necessitate as a 
minimum a microenvironment in which foci of local alkalinity would remain 
sustained over time. It has been shown in this context, and our findings (Table II) 
prove it for rat brain mb-MAPs, that treatment of MAPs with ammonia [22,25] 
generates new carboxylmethylatable sites by converting susceptible natural 
aspartate/asparagines to "atypical" forms of amino acids [5,9]. This test tube 
reaction may be viewed, therefore, as the single macro event which telescopes, in a 
very short time and under man-made laboratory conditions, the presumed recurrent 
micro events which result in situ in net increases of mb proteins containing unnatural 
aspartate residues. The function of these increments in mb-MAP content per se, in 
the context of biological aging of membranes or in terms of the indirect effects of 
such age-induced mb-protein modifications on the behavior of cytoskeletal 
structures into which mb-MAPs are naturally embedded, is unclear at this time. Our 
findings (Table II) of a significant reduction in the effectiveness of the ammonia 
treatment to generate new carboxylmethylatable sites in cerebral mb-MAPs of old, 
relative to young, six-times washed membranes strongly infers the possibility that 
modifications similar to those ammonia is able to produce in the test tube, do 
continue to be generated as young membranes mature, reach middle-age and 
continue on to become old and very old. 
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